Utilizing machine learning for early screening of thyroid nodules: a dual-center cross-sectional study in China

被引:0
|
作者
Weng, Shuwei [1 ,2 ]
Ding, Chen [3 ]
Hu, Die [1 ,2 ]
Chen, Jin [1 ,2 ]
Liu, Yang [4 ]
Liu, Wenwu [1 ,2 ]
Chen, Yang [1 ,2 ]
Guo, Xin [1 ,2 ]
Cao, Chenghui [1 ,2 ]
Yi, Yuting [1 ,2 ]
Yang, Yanyi [5 ,6 ]
Peng, Daoquan [1 ,2 ]
机构
[1] Cent South Univ, Xiangya Hosp 2, Dept Cardiol, Changsha, Hunan, Peoples R China
[2] Res Inst Blood Lipid & Atherosclerosis, Changsha, Hunan, Peoples R China
[3] Soochow Univ, Affiliated Hosp 4, Suzhou Dushu Lake Hosp, Dept Cardiol,Med Ctr, Suzhou, Jiangsu, Peoples R China
[4] Third Mil Med Univ, Xinqiao Hosp,Army Med Univ, Chongqing Clin Res Ctr Kidney & Urol Dis, Dept Nephrol,Key Lab Prevent & Treatment Chron Kid, Chongqing, Peoples R China
[5] Cent South Univ, Xiangya Hosp 2, Hlth Management Ctr, Changsha, Hunan, Peoples R China
[6] Hunan Prov Clin Med Res Ctr Intelligent Management, Changsha, Hunan, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2024年 / 15卷
基金
中国国家自然科学基金;
关键词
thyroid nodule; machine learning; early screening; urine iodine; ensemble learning methods; IODINE INTAKE; ASSOCIATION; MANAGEMENT; DIAGNOSIS; AGE;
D O I
10.3389/fendo.2024.1385167
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Thyroid nodules, increasingly prevalent globally, pose a risk of malignant transformation. Early screening is crucial for management, yet current models focus mainly on ultrasound features. This study explores machine learning for screening using demographic and biochemical indicators.Methods Analyzing data from 6,102 individuals and 61 variables, we identified 17 key variables to construct models using six machine learning classifiers: Logistic Regression, SVM, Multilayer Perceptron, Random Forest, XGBoost, and LightGBM. Performance was evaluated by accuracy, precision, recall, F1 score, specificity, kappa statistic, and AUC, with internal and external validations assessing generalizability. Shapley values determined feature importance, and Decision Curve Analysis evaluated clinical benefits.Results Random Forest showed the highest internal validation accuracy (78.3%) and AUC (89.1%). LightGBM demonstrated robust external validation performance. Key factors included age, gender, and urinary iodine levels, with significant clinical benefits at various thresholds. Clinical benefits were observed across various risk thresholds, particularly in ensemble models.Conclusion Machine learning, particularly ensemble methods, accurately predicts thyroid nodule presence using demographic and biochemical data. This cost-effective strategy offers valuable insights for thyroid health management, aiding in early detection and potentially improving clinical outcomes. These findings enhance our understanding of the key predictors of thyroid nodules and underscore the potential of machine learning in public health applications for early disease screening and prevention.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Gender-Specific Associations Between Metabolic Disorders and Thyroid Nodules: A Cross-Sectional Population-Based Study from China
    Zhang, Fan
    Teng, Di
    Tong, Nanwei
    Wang, Guixia
    Li, Yongze
    Yu, Xiaohui
    Shan, Zhongyan
    Teng, Weiping
    THYROID, 2022, 32 (05) : 571 - 580
  • [42] Optimized concurrent hearing and genetic screening in Beijing, China: A cross-sectional study
    Wen, Cheng
    Yang, Xiaozhe
    Cheng, Xiaohua
    Zhang, Wei
    Li, Yichen
    Wang, Jing
    Wang, Chuan
    Ruan, Yu
    Zhao, Liping
    Lu, Hongli
    Li, Yingxin
    Bai, Yue
    Yu, Yiding
    Li, Yue
    Xie, Jinge
    Qi, Bei-er
    En, Hui
    Liu, Hui
    Fu, Xinxing
    Huang, Lihui
    Han, Demin
    BIOSCIENCE TRENDS, 2023, 17 (02) : 148 - 159
  • [43] Determinants of gastric cancer screening attendance in Southeastern China: a cross-sectional study
    Huang, Zhiwen
    Hu, Zhijian
    Wong, Li Ping
    Lin, Yulan
    BMJ OPEN, 2023, 13 (07):
  • [44] Using machine learning approach to predict depression and anxiety among patients with epilepsy in China: A cross-sectional study
    Wei, Zihan
    Wang, Xinpei
    Ren, Lei
    Liu, Chang
    Liu, Chao
    Cao, Mi
    Feng, Yan
    Gan, Yanjing
    Li, Guoyan
    Liu, Xufeng
    Liu, Yonghong
    Yang, Lei
    Deng, Yanchun
    JOURNAL OF AFFECTIVE DISORDERS, 2023, 336 : 1 - 8
  • [45] Identifying the Influencing Factors of Depressive Symptoms among Nurses in China by Machine Learning: A Multicentre Cross-Sectional Study
    Li, Shu
    Sznajder, Kristin K.
    Ning, Lingfang
    Gao, Hong
    Xie, Xinyue
    Liu, Shuo
    Shao, Chunyu
    Li, Xinru
    Yang, Xiaoshi
    JOURNAL OF NURSING MANAGEMENT, 2023, 2023
  • [46] Comparison of Different Ultrasound Classification Systems of Thyroid Nodules for Identifying Malignant Potential: A Cross-sectional Study
    Chen, Hua
    Ye, Jun
    Song, Jianming
    You, Yuguang
    Chen, Weihua
    Liu, Yanna
    CLINICS, 2021, 76 : 1 - 7
  • [47] The Prevalence of Single and Multiple Thyroid Nodules and Its Association with Metabolic Diseases in Chinese: A Cross-Sectional Study
    Zou, Bing
    Sun, Li
    Wang, Xin
    Chen, Zongtao
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2020, 2020
  • [48] Prevalence and predictors of thyroid nodules among adults: analyzing the association with metabolic syndrome in a cross-sectional study
    Abrishami, Golbarg
    Emadzadeh, Maryam
    Bakhshi, Aida
    Moeinipour, Yasamin
    Taghavi, Ghazaleh
    Hasani, Solmaz
    BMC ENDOCRINE DISORDERS, 2025, 25 (01)
  • [49] Influence of metabolic syndrome and lifestyle factors on thyroid nodules in Chinese adult men: a cross-sectional study
    Wan, Ziyu
    Li, Ying
    Dong, Xiaoqian
    Kang, Yue
    Luo, Juan
    Wang, Jiangang
    Yang, Pingting
    Wang, Yaqin
    Duan, Yinglong
    Xie, Jianfei
    Cheng, Andy S. K.
    EUROPEAN THYROID JOURNAL, 2023, 12 (06)
  • [50] A study of machine learning models for rapid intraoperative diagnosis of thyroid nodules for clinical practice in China
    Ma, Yan
    Zhang, Xiuming
    Yi, Zhongliang
    Ding, Liya
    Cai, Bojun
    Jiang, Zhinong
    Liu, Wangwang
    Zou, Hong
    Wang, Xiaomei
    Fu, Guoxiang
    CANCER MEDICINE, 2024, 13 (03):